Stockscreener 앱 받기
9.71
3.08%
0.29
시간 외 거래:
9.80
0.09
+0.93%
Regenxbio Inc 주식(RGNX)의 최신 뉴스
What recovery options are there for REGENXBIO Inc.2025 Risk Factors & Expert Approved Momentum Ideas - Newser
REGENXBIO Inc. recovery potential after sell offAnalyst Downgrade & Safe Entry Zone Identification - Newser
Regenxbio: Remains A "Buy Rating" Despite BLA Review Delay Of RGX-121 For Hunter Syndrome (NASDAQ:RGNX) - Seeking Alpha
Can REGENXBIO Inc. expand into new markets2025 Earnings Surprises & Advanced Technical Signal Analysis - خودرو بانک
Top chart patterns to watch in REGENXBIO Inc.Weekly Investment Recap & AI Optimized Trading Strategy Guides - Newser
Is REGENXBIO Inc.’s ROIC above industry averageTreasury Yields & Real-Time Stock Movement Alerts - خودرو بانک
Goldman Sachs reiterates Neutral rating on Regenxbio stock at $14 target - Investing.com Australia
REGENXBIO reports positive one-year data for MPS II gene therapy - Investing.com Nigeria
Should value investors consider REGENXBIO Inc.2025 Stock Rankings & Daily Stock Trend Reports - خودرو بانک
Goldman Sachs reiterates Neutral rating on Regenxbio stock at $14 target By Investing.com - Investing.com South Africa
Can REGENXBIO Inc. expand its profit marginsWeekly Risk Report & Free Reliable Trade Execution Plans - خودرو بانک
Regenxbio stock maintains Outperform rating at Raymond James on MPS II data - Investing.com Nigeria
Regenxbio stock maintains Outperform rating at Raymond James on MPS II data By Investing.com - Investing.com South Africa
Will REGENXBIO Inc. bounce back from current supportQuarterly Profit Summary & Safe Investment Capital Preservation Plans - Newser
Risk adjusted return profile for REGENXBIO Inc. analyzed2025 Price Targets & Low Risk Entry Point Tips - Newser
Regenxbio Unveils 12-Month Data For Gene Therapy Soon After FDA Delays Review Date - Benzinga
Long term hold vs stop loss in REGENXBIO Inc.Fed Meeting & Daily Oversold Bounce Ideas - Newser
Regenxbio trumpets one-year data for Hunter syndrome gene therapy after FDA extended its review - Endpoints News
REGENXBIO reports positive data from Hunter syndrome (RGNX) - Seeking Alpha
Navigating Biotech Innovation Amid Sector Volatility: High-Conviction Opportunities in 2025 - AInvest
Sector Update: Health Care Stocks Mixed Pre-Bell Friday - MarketScreener
RGX-121 and the Path to Accelerated FDA Approval: A Strategic Inflection Point for REGENXBIO - AInvest
Can machine learning forecast REGENXBIO Inc. recoveryWeekly Trend Summary & Consistent Growth Equity Picks - Newser
82% Brain Disease Marker Drop: REGENXBIO's One-Time Hunter Syndrome Treatment Shows Promise in Pivotal Trial - Stock Titan
What MACD signals say about REGENXBIO Inc.Trend Reversal & Free Safe Capital Growth Stock Tips - Newser
Should you wait for a breakout in REGENXBIO Inc.2025 Fundamental Recap & High Accuracy Investment Signals - Newser
Multi factor analysis applied to REGENXBIO Inc.July 2025 Rallies & Comprehensive Market Scan Reports - Newser
How to monitor REGENXBIO Inc. with trend dashboardsQuarterly Earnings Report & Safe Capital Growth Tips - Newser
Analyzing REGENXBIO Inc. with multi timeframe charts2025 Buyback Activity & Safe Capital Growth Stock Tips - Newser
News impact scoring models applied to REGENXBIO Inc.July 2025 Review & Long Hold Capital Preservation Plans - Newser
Can trapped investors hope for a rebound in REGENXBIO Inc.2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - Newser
What high frequency data says about REGENXBIO Inc.2025 Technical Overview & Reliable Volume Spike Alerts - Newser
What is REGENXBIO Inc. s debt to equity ratioTrade Volume Summary & Real-Time Volume Triggers - خودرو بانک
Candlestick signals on REGENXBIO Inc. stock todayJuly 2025 Pullbacks & AI Forecasted Entry and Exit Points - Newser
Order Flow Trends Show Accumulation in REGENXBIO Inc.Market Performance Report & Community Consensus Picks - beatles.ru
What’s next for REGENXBIO Inc. stock price2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
REGENXBIO Inc. Stocks Attracting Dip Buyers getLinesFromResByArray error: size == 0 - thegnnews.com
Strategies to average down on REGENXBIO Inc.July 2025 Recap & Free Daily Entry Point Trade Alerts - Newser
Will REGENXBIO Inc. stock go up in YEARJuly 2025 Sector Moves & Stepwise Trade Signal Implementation - خودرو بانک
Signal strength of REGENXBIO Inc. stock in tech scannersPortfolio Value Summary & Low Risk High Reward Trade Ideas - Newser
Trend analysis for REGENXBIO Inc. this weekMarket Volume Report & Daily Entry Point Trade Alerts - Newser
Can REGENXBIO Inc. be recession proofJuly 2025 Retail & Weekly High Return Forecasts - خودرو بانک
How institutional ownership impacts REGENXBIO Inc. stockQuarterly Market Summary & Free High Return Stock Watch Alerts - Newser
Applying Wyckoff theory to REGENXBIO Inc. stockM&A Rumor & Pattern Based Trade Signal System - Newser
Has REGENXBIO Inc. found a price floorRisk Management & Free High Accuracy Swing Entry Alerts - Newser
Is this a good reentry point in REGENXBIO Inc.Weekly Stock Summary & Expert Verified Movement Alerts - Newser
1.40%
자본화:
|
볼륨(24시간):